Benzinga's Top Upgrades, Downgrades For May 16, 2017

Top Upgrades

• Argus Research upgraded Yum! Brands, Inc. YUM from Hold to Buy. Yum Brands shares rose 0.46 percent to close at $69.22 on Monday.
• Analysts at Morgan Stanley upgraded Dr Pepper Snapple Group Inc. DPS from Equal-Weight to Overweight. Dr Pepper Snapple shares gained 0.87 percent to $91.88 in pre-market trading.
• Canaccord Genuity upgraded Crane Co. CR from Hold to Buy. Crane shares rose 0.98 percent to close at $78.55 on Monday.
• Analysts at Bernstein upgraded TechnipFMC plc FTI from Underperform to Market Perform. TechnipFMC shares rose 1.08 percent to $31.79 in pre-market trading.
• Analysts at Wells Fargo upgraded LGI Homes Inc LGIH from Underperform to Market Perform. LGI Homes shares gained 2.96 percent to close at $32.69 on Monday.
• Analysts at Baird upgraded Triumph Group Inc TGI from Underperform to Outperform. Triumph Group shares gained 4.16 percent to $21.30 in pre-market trading.
• Loop Capital upgraded Regal Entertainment Group RGC from Hold to Buy. Regal Entertainment shares dropped 2.63 percent to close at $20.74 on Monday.
• Morgan Stanley upgraded American International Group Inc AIG from Equal-Weight to Overweight. AIG shares climbed 1.13 percent to $62.52 in pre-market trading.
• Goldman Sachs upgraded Delek US Holdings, Inc. DK from Neutral to Buy. Delek US shares rose 2.64 percent to $25.30 in pre-market trading.

Top Downgrades

• Citigroup downgraded Pfizer Inc. PFE from Neutral to Sell. Pfizer shares fell 1.66 percent to $32.57 in pre-market trading.
• Jefferies downgraded Patheon NV PTHN from Buy to Hold. Patheon shares climbed 33.08 percent to close at $34.60 on Monday.
• RBC Capital downgraded Forterra Inc FRTA from Outperform to Sector Perform. Forterra shares fell 24.29 percent to close at $14.93 on Monday.
• Wells Fargo downgraded M.D.C. Holdings, Inc. MDC from Market Perform to Underperform. M.D.C. Holdings shares slipped 1.15 percent to $35.22 in pre-market trading.
• Goldman Sachs downgraded Valero Energy Corporation VLO from Buy to Neutral. Valero Energy shares dropped 0.61 percent to $65.15 in pre-market trading.
• JP Morgan downgraded Mercadolibre Inc MELI from Overweight to Neutral. MercadoLibre shares fell 1.73 percent to $291.12 in pre-market trading.
• Morgan Stanley downgraded Church & Dwight Co., Inc. CHD from Equal-Weight to Underweight. Church & Dwight shares slipped 0.60 percent to $49.95 in pre-market trading.

Top Initiations

• Goldman Sachs initiated coverage of Intuitive Surgical, Inc. ISRG with a Buy rating. The price target for Intuitive Surgical is set to $1,000. Intuitive Surgical shares closed at $850.67 on Monday.
• Loop Capital initiated coverage on Whole Foods Market, Inc. WFM with a Hold rating. The price target for Whole Foods is set to $35. Whole Foods shares closed at $36.44 on Monday.
• Analysts at Needham initiated coverage of SAGE Therapeutics Inc SAGE with a Buy rating. The price target for SAGE Therapeutics is set to $82. SAGE Therapeutics shares closed at $70.67 on Monday.
• Analysts at Berenberg initiated coverage on Pinnacle Foods Inc PF with a Buy rating. The price target for Pinnacle Foods is set to $68. Pinnacle Foods shares closed at $58.36 on Monday.
• Analysts at Goldman Sachs initiated coverage on Stryker Corporation SYK with a Neutral rating. The price target for Stryker is set to $129. Stryker shares closed at $136.03 on Monday.
• FBR Capital initiated coverage on Select Energy Services Inc WTTR with an Outperform rating. The price target for Select Energy is set to $23. Select Energy shares closed at $15.29 on Monday.
• Analysts at Stephens & Co. initiated coverage on Hostess Brands, Inc. TWNK with an Overweight rating. The price target for Hostess Brands is set to $20. Hostess Brands shares closed at $16.00 on Monday.
• Loop Capital initiated coverage on Kroger Co KR with a Hold rating. The price target for Kroger is set to $32. Kroger shares closed at $29.14 on Monday.
• Analysts at Goldman Sachs initiated coverage on Edwards Lifesciences Corp EW with a Buy rating. The price target for Edwards Lifesciences is set to $138. Edwards Lifesciences shares closed at $113.43 on Monday.